AnalystsRobert DriscollRobert Driscoll's Stock Forecasts
AnalystsRobert Driscoll
Sectors:
Industries:
Analyst Ranking
Top 15%
#737 out of 5105 analysts
Average Return
+7.44%
Win Rate
37%62 out of 167
Risk vs Reward
Poor
Good
Robert Driscoll's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Janux Therapeutics IncJANX | +718.88% | $6.62 | $54.21 | 2023-11-08 - 2024-11-07 | Buy |
Five Prime Therapeutics IncFPRX | +494.68% | $6.39 | $38.00 | 2020-06-22 - 2021-04-15 | Buy |
Alpine Immune Sciences IncALPN | +414.33% | $12.63 | $64.96 | 2023-11-15 - 2024-05-16 | Buy |
Alpine Immune Sciences IncALPN | +403.57% | $12.90 | $64.96 | 2023-09-01 - 2024-05-16 | Buy |
Alpine Immune Sciences IncALPN | +381.19% | $13.50 | $64.96 | 2023-08-15 - 2024-05-16 | Buy |
Robert Driscoll Analyst Color
Get additional color on Robert Driscoll's coverage of popular stocks
Robert Driscoll's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kura Oncology IncKURA | 10 | Buy | $38.00 | +240.20% | Maintains | 10 days ago |
Revolution Medicines IncRVMD | 8 | Buy | $80.00 | +12.88% | Maintains | 18 days ago |
Corbus Pharmaceuticals Holdings IncCRBP | 2 | Buy | $38.00 | +216.40% | Maintains | a month ago |
Replimune Group IncREPL | 6 | Buy | $18.00 | +95.65% | Upgrades | a month ago |
Crescent Biopharma IncCBIO | 1 | Buy | $27.00 | +106.74% | Initiates Coverage On | 4 months ago |
Zentalis Pharmaceuticals IncZNTL | 11 | Hold | $4.00 | +198.51% | Reiterates | 6 months ago |
Werewolf Therapeutics IncHOWL | 3 | Buy | $6.00 | +587.29% | Maintains | 6 months ago |
Monte Rosa Therapeutics IncGLUE | 4 | Buy | $17.00 | +19.55% | Maintains | 8 months ago |
Arvinas IncARVN | 7 | Hold | $12.00 | +4.17% | Downgrades | 8 months ago |
Day One Biopharmaceuticals IncDAWN | 6 | Buy | $32.00 | +275.59% | Reiterates | 9 months ago |
Ideaya Biosciences IncIDYA | 9 | Buy | $52.00 | +52.99% | Reiterates | a year ago |
Tyra Biosciences IncTYRA | 8 | Buy | $28.00 | N/A | Reiterates | a year ago |
Black Diamond Therapeutics IncBDTX | 9 | Buy | $16.00 | N/A | Reiterates | a year ago |
Arcus Biosciences IncRCUS | 7 | Buy | $30.00 | N/A | Reiterates | a year ago |
Igm Biosciences IncIGMS | 9 | Buy | $22.00 | N/A | Maintains | a year ago |
Adicet Bio IncACET | 8 | Buy | $5.00 | N/A | Reiterates | a year ago |
Cullinan Therapeutics IncCGEM | 4 | Buy | $36.00 | N/A | Reiterates | a year ago |
Aprea Therapeutics IncAPRE | 3 | Buy | $11.00 | N/A | Reiterates | a year ago |
Foghorn Therapeutics IncFHTX | 5 | Buy | $13.00 | N/A | Reiterates | a year ago |
Tango Therapeutics IncTNGX | 4 | Buy | $13.00 | N/A | Maintains | a year ago |
Janux Therapeutics IncJANX | 7 | Buy | $74.00 | N/A | Reiterates | a year ago |
Omega Therapeutics IncOMGAQ | 4 | Buy | $12.00 | N/A | Reiterates | a year ago |
Compass Therapeutics IncCMPX | 2 | Buy | $8.00 | N/A | Reiterates | a year ago |
Geron CorpGERN | 8 | Buy | $7.00 | N/A | Reiterates | a year ago |
Alpine Immune Sciences IncALPN | 7 | Hold | $65.00 | N/A | Reiterates | 2 years ago |
Cytomx Therapeutics IncCTMX | 6 | Buy | $8.00 | N/A | Upgrades | 2 years ago |
Elevation Oncology IncELEV | 7 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Atreca IncBCEL | 4 | Hold | $1.00 | N/A | Downgrades | 2 years ago |
Cyteir Therapeutics IncCYTT | 3 | Buy | $3.00 | N/A | Reiterates | 3 years ago |
Surface Oncology IncSURF | 1 | Buy | $3.00 | N/A | Reiterates | 3 years ago |
Imago Biosciences IncIMGO | 2 | Hold | $36.00 | N/A | Downgrades | 3 years ago |
Harpoon Therapeutics IncHARP | 3 | Buy | $70.00 | N/A | Upgrades | 4 years ago |
Entasis Therapeutics Holdings IncETTX | 1 | Hold | $1.80 | N/A | Downgrades | 4 years ago |
Aceragen IncACGN | 2 | Hold | $1.00 | N/A | Downgrades | 5 years ago |
Five Prime Therapeutics IncFPRX | 4 | Buy | $9.00 | N/A | Upgrades | 5 years ago |
Arbutus Biopharma CorpABUS | 4 | Buy | $4.00 | N/A | Upgrades | 6 years ago |
Nabriva Therapeutics PLCNBRVF | 1 | Hold | $250.00 | N/A | Downgrades | 6 years ago |
Paratek Pharmaceuticals IncPRTK | 1 | Buy | $34.00 | N/A | Reiterates | 9 years ago |
Sierra Oncology IncSRRA | 1 | Buy | $4.00 | N/A | Upgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.